Recormon (Roche) - General Information:

Human erythropoietin (recombinant), produced by CHO cells.

Pharmacology:

Used in the treatment of anemia. Involved in the regulation of erythrocyte differentiation and the maintenance of a physiological level of circulating erythrocyte mass.

Recormon (Roche) for patients

Recormon (Roche) Interactions

No evidence of interaction of PROCRIT with other drugs was observed in the course of clinical trials.  

Recormon (Roche) Contraindications

PROCRIT is contraindicated in patients with:  

1. Uncontrolled hypertension

2. Known hypersensitivity to mammalian cell-derived products

3. Known hypersensitivity to Albumin (Human)

 

Additional information about Recormon (Roche)

Recormon (Roche) Indication: For treatment of anemia (from renal transplants or certain HIV treatment)
Mechanism Of Action: Binding of erythropoietin to the erythropoietin receptor leads to receptor dimerization, which facilitates activation of JAK-STAT signaling pathways within the cytosol. Activated STAT (signal transducers and activators of transcription) proteins are then translocated to the nucleus where they serve as transcription factors which regulate the activation of specific genes involved in cell division or differentiation.
Drug Interactions: Not Available
Food Interactions: Not Available
Generic Name: Epoetin alfa
Synonyms: Epoetin; Erythropoietin precursor
Drug Category: Antianemic Agents
Drug Type: Biotech; Approved
Other Brand Names containing Epoetin alfa: Epogen (Amgen Inc.); Epogin (Chugai); Epomax (Elanex); Eprex (Janssen-Cilag. Ortho Biologics LLC); NeoRecormon (Roche); Procrit (Ortho Biotech); Recormon (Roche);
Absorption: Not Available
Toxicity (Overdose): Not Available
Protein Binding: Not Available
Biotransformation: Not Available
Half Life: Not Available
Dosage Forms of Recormon (Roche): Liquid Subcutaneous
Solution Subcutaneous
Solution Intravenous
Chemical IUPAC Name: Human erythropoietin
Chemical Formula: C815H1317N233O241S5
Epoetin alfa on Wikipedia: http://en.wikipedia.org/wiki/Epoetin_alfa
Organisms Affected: Humans and other mammals

Bookmark or Share this page


»Get link codes for this page«
(HTML/BB code)



Search by name browsing our [A-Z] index:

ABCDEFGHI
JKLMNOPQR
STUVWXYZ

Search by Categories:

See a list of all drugs for sale »

Top5 meds in current month:

*based on number of page views on Flexyx

Visit our friends:

brand and generic ed pills Russian Scientific Center for Restorative Traumatology and Orthopaedics in the name of academician G.A.Ilizarov

Related News

Fri, 02 Jul 2010
Health Sciences Authority - 2005
Dear Healthcare Professional Letters (DHCPL) in 2005. Details of the Dear Healthcare Professional Letters can be found on the Health Professionals Portal (HPP) HPP was developed for all healthcare professionals in Singapore.
Source: www.hsa.gov.sg »

Mon, 19 Apr 2010
Health Sciences Authority - Erythropoietin stimulating agents (ESAs) - A safety update
Erythropoietin stimulating agents (ESAs): A safety update. HSA would like to remind healthcare professionals of key safety issues associated with the use of erythropoietin stimulating agents (ESAs).
Source: www.hsa.gov.sg »

Wed, 20 Aug 2008
PLoS ONE - The Ergogenic Effect of Recombinant Human Erythropoietin on V̇O2max Depends on the Severity ...
The Ergogenic Effect of Recombinant Human Erythropoietin on V̇O2max Depends on the Severity of Arterial Hypoxemia. EzReprint New & improved. See all categories. Share this Article. 1 Ecole Nationale de Ski et d'Alpinisme, Chamonix, France.
Source: www.plosone.org »



Thanks for visiting us!